Serum procalcitonin a reliable biomarker
Ventilator-associated pneumonia (VAP) is a major hospital-acquired infection that accentuates morbidities in an already sick child and negatively impacts recovery and prognosis. Variuos morbidities associated with VAP included prolonged ventilation, long duration of higher antibiotics, increased ICU and hospital stay subsequently leading to increased health care costs.Early identification of...
Ventilator-associated pneumonia (VAP) is a major hospital-acquired infection that accentuates morbidities in an already sick child and negatively impacts recovery and prognosis. Variuos morbidities associated with VAP included prolonged ventilation, long duration of higher antibiotics, increased ICU and hospital stay subsequently leading to increased health care costs.
Early identification of an evolving VAP helps in the early optimization of antibiotic therapy and correlates with early weaning from mechanical ventilation. For this purpose researchers from RML hospital New Delhi conducted a study to determine the role of serum procalcitonin as an early inflammatory marker for an early and provisional diagnosis of VAP among clinically suspected VAP patients in pediatric intensive care unit settings.
For more details, check out the full story on the link below:
Serum Procalcitonin- Reliable Biomarker To Diagnose Ventilator Associated Pneumonia In Kids: Study
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd